Trial Profile

Intra-patient Randomized Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT Follow up

Status: Completed

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 22 Jun 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sirolimus (Primary)
Indications Coronary artery disease
Focus Therapeutic Use
Acronyms FRIENDLY-OCT TRIAL

Most Recent Events

20 Jun 2022 Primary endpoint has been met. (the difference in the proportion of covered struts at 3 months), as per published in the International Journal of Cardiology
20 Jun 2022 Results evaluating the potential better early healing of a novel probucol coated polymer free ultra-thin strut sirolimus eluting stent, published in the International Journal of Cardiology
11 Jan 2022 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com